logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10183008 B1

PDFFull Text
Date of Patent:
Jan. 22, 2019

Filed:

Sep. 19, 2012

Treatment of prolonged status epilepticus

Applicant:

University of South Carolina, Columbia, SC (US);

Inventors:

David D. Mott, Columbia, SC (US);

Janet L. Fisher, Columbia, SC (US);

Rene H. Levy, Seattle, WA (US);

Marie-Emmanuelle LeGuern, Compiegne, FR;

Marc Verleye, Compiegne, FR;

Bernard Hublot, Compiegne, FR;

Assignee:

University of South Carolina, Columbia, SC (US);

Attorney:

Dority & Manning, P.A.

Primary Examiner:

Anna Pagonakis

Int. Cl.
CPC ...
A61K 31/357 (2006.01); A61K 31/5513 (2006.01); A61K 31/135 (2006.01); A61K 31/165 (2006.01); A61K 31/167 (2006.01); A61K 31/20 (2006.01); A61K 31/36 (2006.01); A61K 31/4015 (2006.01); A61K 31/4166 (2006.01); A61K 31/515 (2006.01); A61K 31/55 (2006.01); A61K 31/5517 (2006.01); A61K 31/661 (2006.01); A61K 31/7048 (2006.01);
U.S. Cl.
CPC ...
A61K 31/357 (2013.01); A61K 31/135 (2013.01); A61K 31/165 (2013.01); A61K 31/167 (2013.01); A61K 31/20 (2013.01); A61K 31/36 (2013.01); A61K 31/4015 (2013.01); A61K 31/4166 (2013.01); A61K 31/515 (2013.01); A61K 31/55 (2013.01); A61K 31/5513 (2013.01); A61K 31/5517 (2013.01); A61K 31/661 (2013.01); A61K 31/7048 (2013.01);
Abstract

Methods for terminating, preventing, and/or treating status epilepticus are generally provided. The method can include administering a prophylactically or therapeutically effective amount of stiripentol or a related compound thereof to an individual in need of treatment of status epilepticus. The individual can be in need of treatment of prolonged status epilepticus, refractory status epilepticus, and/or benzodiazepine-resistant status epilepticus.

Find Patent Forward Citations

Loading…